Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wittman

Showing results (241-250 of 286) with videos related to

Pageof 29
Sort By:
Journal of Medicinal Chemistry|December 14, 2001
Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476T J Altstadt, C R Fairchild, J Golik, et al.
Contemporary Clinical Trials|February 6, 2023
Study protocol for a multisite randomized controlled trial of a peer navigator intervention for emergency department patients with nonfatal opioid overdoseKelly M Doran, Alice E Welch, Angela Jeffers, et al.
JMIR Research Protocols|November 3, 2021
Correction: The Good Food for Learning Universal Curriculum-Integrated Healthy School Lunch Intervention: Protocol for a Two-Year Matched Control Pre-Post and Case StudyRachel Engler-Stringer, Jennifer Black, Nazeem Muhajarine, et al.
Cancer Research|January 7, 2006
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417Paul Haluska, Joan M Carboni, David A Loegering, et al.
Plos One|December 18, 2025
Diagnostic accuracy and risk stratification of the score for trauma triage in the geriatric and middle-aged among older adults with fall-related injuriesOluwaseun John Adeyemi, Sanjit Konda, Charles DiMaggio, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinaseMark D Wittman, Balu Balasubramanian, Karen Stoffan, et al.
JMIR Research Protocols|September 21, 2021
The Good Food for Learning Universal Curriculum-Integrated Healthy School Lunch Intervention: Protocol for a Two-Year Matched Control Pre-Post and Case StudyRachel Engler-Stringer, Jennifer Black, Nazeem Muhajarine, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2008
2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924Mark G Saulnier, David B Frennesson, Mark D Wittman, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-oneUpender Velaparthi, Mark G Saulnier, Mark D Wittman, et al.
Pageof 29

Showing results (241-250 of 286) with videos related to

Sort By:
Pageof 29
Journal of Medicinal Chemistry|December 14, 2001
Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476T J Altstadt, C R Fairchild, J Golik, et al.
Contemporary Clinical Trials|February 6, 2023
Study protocol for a multisite randomized controlled trial of a peer navigator intervention for emergency department patients with nonfatal opioid overdoseKelly M Doran, Alice E Welch, Angela Jeffers, et al.
JMIR Research Protocols|November 3, 2021
Correction: The Good Food for Learning Universal Curriculum-Integrated Healthy School Lunch Intervention: Protocol for a Two-Year Matched Control Pre-Post and Case StudyRachel Engler-Stringer, Jennifer Black, Nazeem Muhajarine, et al.
Cancer Research|January 7, 2006
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417Paul Haluska, Joan M Carboni, David A Loegering, et al.
Plos One|December 18, 2025
Diagnostic accuracy and risk stratification of the score for trauma triage in the geriatric and middle-aged among older adults with fall-related injuriesOluwaseun John Adeyemi, Sanjit Konda, Charles DiMaggio, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinaseMark D Wittman, Balu Balasubramanian, Karen Stoffan, et al.
JMIR Research Protocols|September 21, 2021
The Good Food for Learning Universal Curriculum-Integrated Healthy School Lunch Intervention: Protocol for a Two-Year Matched Control Pre-Post and Case StudyRachel Engler-Stringer, Jennifer Black, Nazeem Muhajarine, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2008
2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924Mark G Saulnier, David B Frennesson, Mark D Wittman, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitorsKurt Zimmermann, Mark D Wittman, Mark G Saulnier, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-oneUpender Velaparthi, Mark G Saulnier, Mark D Wittman, et al.
Pageof 29